BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 15935452)

  • 21. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripunyo K; Pokum S
    J Med Assoc Thai; 2000 May; 83(5):536-42. PubMed ID: 10863900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene.
    Zak I; Niemiec P; Sarecka B; Balcerzyk A; Ciemniewski Z; Rudowska E; Dylag S
    Acta Biochim Pol; 2003; 50(2):527-34. PubMed ID: 12833177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case-control study on the relationship between abnormal homocysteine metabolism and essential hypertension].
    Zhan S; Gao Y; Yin X; Huang Y; Hu Y; Li L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):194-7. PubMed ID: 11860783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.
    De Marco P; Calevo MG; Moroni A; Arata L; Merello E; Cama A; Finnell RH; Andreussi L; Capra V
    Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S14-7. PubMed ID: 11813127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia.
    Brown KS; Kluijtmans LA; Young IS; Woodside J; Yarnell JW; McMaster D; Murray L; Evans AE; Boreham CA; McNulty H; Strain JJ; Mitchell LE; Whitehead AS
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1014-20. PubMed ID: 12689917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
    Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
    Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.
    Botto N; Andreassi MG; Manfredi S; Masetti S; Cocci F; Colombo MG; Storti S; Rizza A; Biagini A
    Eur J Hum Genet; 2003 Sep; 11(9):671-8. PubMed ID: 12939653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly women.
    Kauwell GP; Wilsky CE; Cerda JJ; Herrlinger-Garcia K; Hutson AD; Theriaque DW; Boddie A; Rampersaud GC; Bailey LB
    Metabolism; 2000 Nov; 49(11):1440-3. PubMed ID: 11092508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida.
    Wilson A; Platt R; Wu Q; Leclerc D; Christensen B; Yang H; Gravel RA; Rozen R
    Mol Genet Metab; 1999 Aug; 67(4):317-23. PubMed ID: 10444342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects.
    Zijno A; Andreoli C; Leopardi P; Marcon F; Rossi S; Caiola S; Verdina A; Galati R; Cafolla A; Crebelli R
    Carcinogenesis; 2003 Jun; 24(6):1097-103. PubMed ID: 12807760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population.
    Richter B; Stegmann K; Röper B; Böddeker I; Ngo ET; Koch MC
    J Hum Genet; 2001; 46(3):105-9. PubMed ID: 11310576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene.
    Vilaseca MA; Monrós E; Artuch R; Colomé C; Farré C; Valls C; Cardo E; Pineda M
    Eur J Paediatr Neurol; 2000; 4(6):269-77. PubMed ID: 11277368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.
    Kawamoto R; Kohara K; Tabara Y; Miki T; Doi T; Tokunaga H; Konishi I
    J Hum Genet; 2001; 46(9):506-10. PubMed ID: 11558898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study.
    Dierkes J; Jeckel A; Ambrosch A; Westphal S; Luley C; Boeing H
    Metabolism; 2001 Jun; 50(6):640-5. PubMed ID: 11398138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polymorphism of genes coding for angiotensin I converting enzyme and methylenetetrahydrofolate reductase in patients with ischemic heart disease].
    Goracy I
    Ann Acad Med Stetin; 2000; 46():97-108. PubMed ID: 11712321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor.
    Molloy AM; Mills JL; Kirke PN; Ramsbottom D; McPartlin JM; Burke H; Conley M; Whitehead AS; Weir DG; Scott JM
    Am J Med Genet; 1998 Jun; 78(2):155-9. PubMed ID: 9674907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men.
    Zuo M; Nishio H; Lee MJ; Maejima K; Mimura S; Sumino K
    J Hum Genet; 2000; 45(4):257-62. PubMed ID: 10944859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.